Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MS.
Zrzavy T, Rieder K, Wuketich V, Thalhammer R, Haslacher H, Altmann P, Kornek B, Krajnc N, Monschein T, Schmied C, Zebenholzer K, Zulehner G, Berger T, Rommer P, Leutmezer F, Bsteh G. Zrzavy T, et al. Among authors: haslacher h. Front Neurol. 2024 Apr 16;15:1388941. doi: 10.3389/fneur.2024.1388941. eCollection 2024. Front Neurol. 2024. PMID: 38689880 Free PMC article.
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy.
Sieghart D, Hana CA, Dürrschmid C, Heinz LX, Haslacher H, Zlesak M, Piccini G, Manenti A, Montomoli E, Jorda A, Fedrizzi C, Hasenoehrl T, Zdravkovic A, Anderle K, Wiedermann U, Drapalik S, Steinbrecher H, Bergmann F, Firbas C, Jordakieva G, Wagner B, Leonardi M, Pierleoni G, Ballini M, Benincasa L, Marchi S, Trombetta C, Perkmann T, Crevenna R, Zeitlinger M, Bonelli M, Aletaha D, Radner H. Sieghart D, et al. Among authors: haslacher h. J Clin Virol. 2024 Feb 28;173:105661. doi: 10.1016/j.jcv.2024.105661. Online ahead of print. J Clin Virol. 2024. PMID: 38503118
Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome.
Gyöngyösi M, Lukovic D, Mester-Tonczar J, Zlabinger K, Einzinger P, Spannbauer A, Schweiger V, Schefberger K, Samaha E, Bergler-Klein J, Riesenhuber M, Nitsche C, Hengstenberg C, Mucher P, Haslacher H, Breuer M, Strassl R, Puchhammer-Stöckl E, Loewe C, Beitzke D, Hasimbegovic E, Zelniker TA. Gyöngyösi M, et al. Among authors: haslacher h. NPJ Vaccines. 2023 Sep 29;8(1):145. doi: 10.1038/s41541-023-00739-2. NPJ Vaccines. 2023. PMID: 37773184 Free PMC article.
SARS-CoV-2 infections in "less visible" hospital staff: The roles and safety of environmental services and allied health professionals.
Jensen S, Traugott M, Ramazanova D, Haslacher H, Mucher P, Perkmann T, Jeleff M, Kutalek R, Wenisch C, Crevenna R, Jordakieva G. Jensen S, et al. Among authors: haslacher h. J Infect Public Health. 2023 Sep;16(9):1379-1385. doi: 10.1016/j.jiph.2023.05.041. Epub 2023 Jun 2. J Infect Public Health. 2023. PMID: 37437431 Free PMC article.
151 results